Hormone

Exos Reinforces Commitment to Improving Training Outcomes for Clients with Female Physiology through New Partnership with Brianna Battles

Retrieved on: 
Giovedì, Maggio 9, 2024
Education, Therapy, Menstrual cycle, Menopause, National academy, Pregnancy, Sports medicine, Risk, Woman, Hormone, NASM, Partnership, Research, Life, Female, Physiology, Athlete, Exos, Organization, Nursing

PHOENIX, May 9, 2024 /PRNewswire-PRWeb/ -- Exos, the global leader in human performance development and coaching, today announces a partnership with Brianna Battles, strength and conditioning coach and founder of Pregnancy & Postpartum Athleticism, to further advance training education and understanding for performance coaches, physical therapists and other practitioners who train clients with female physiology.

Key Points: 
  • For the last two years, Exos has focused on researching, working in the lab, and studying athletes with female physiology to develop educational resources for industry practitioners.
  • Exos recently released two exclusive online courses, Optimizing Performance Through the Menstrual Cycle and Optimizing Performance Through Menopause , to help practitioners improve training outcomes for their clients.
  • By partnering with Brianna Battles, we can now expand our offering by sharing her expertise in training pregnant and postpartum athletes."
  • To celebrate the partnership between Exos and Brianna Battles, Exos is offering a 25% discount on all Exos and partner certifications and courses through May 16, 2024.

Happy Egg Co. Recruits Local Farms for Free Range Egg Production

Retrieved on: 
Lunedì, Aprile 29, 2024
Fresh water, Weather, Hormone, Partnership, Farmer, Attention, Tree, Farm, Multimedia, Bird, American Humane Certified, Poultry farming

ROGERS, Ark., April 29, 2024 /PRNewswire/ -- Happy Egg Co., the #1 free range egg brand in the nation, according to Nielsen, is recruiting new farmers to thoughtfully raise its Happy hens. With a focus on animal welfare and producing high-quality eggs, Happy Egg seeks to partner with farmers in Arkansas, Missouri, Oklahoma, Kansas, and the surrounding areas (a.k.a. the Heartland of Happy), who share its values and are dedicated to upholding the company's exceptional, American Humane Certified free range farming standards. Headquartered out of Rogers, Arkansas, Happy Egg is a family-owned company that currently works with 100+ independent family farms to produce its eggs. By partnering with more individuals, the company aims to support the livelihoods of local farmers and contribute to the Heartland economy, while meeting growing demand for its free range eggs sold at retailers across the country.

Key Points: 
  • ROGERS, Ark., April 29, 2024 /PRNewswire/ -- Happy Egg Co. , the #1 free range egg brand in the nation, according to Nielsen, is recruiting new farmers to thoughtfully raise its Happy hens.
  • Headquartered out of Rogers, Arkansas, Happy Egg is a family-owned company that currently works with 100+ independent family farms to produce its eggs.
  • Thanks to their dedication to raising the standard, Happy Egg has become the leading free range egg brand in the country.
  • Happy Egg hens are thoughtfully raised with 21.8 square feet of range per bird (that's 10x the space of most free range farms) and given year-round access to the outdoors for 8+ hours a day, weather permitting.

Anti-Mullerian Hormone Test Market Projected to Reach $586.48 million by 2030 - Exclusive Report by 360iResearch

Retrieved on: 
Sabato, Aprile 27, 2024
Use, Polycystic ovary syndrome, Ovarian reserve, PCOS, WHO, Hormone, Danaher Corporation, Primary ovarian insufficiency, Health, World Health Organization, Woman, Infertility, Anti-Müllerian hormone, Health care, AMH, Fertility, Table, Intelligence, IVF, Bio-Rad Laboratories, Privacy, Thermo Fisher Scientific, Diagnosis, POC, Growth, Birth control

Anti-mullerian hormone (AMH) tests are critical in assessing a woman's remaining egg count, potential fertility, and the health of her ovaries.

Key Points: 
  • Anti-mullerian hormone (AMH) tests are critical in assessing a woman's remaining egg count, potential fertility, and the health of her ovaries.
  • A key tool in identifying PCOS is the Anti-Müllerian hormone (AMH) test, which measures the levels of AMH produced by ovarian follicles.
  • We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Anti-Mullerian Hormone Test Market.
  • "Dive into the Anti-Mullerian Hormone Test Market Landscape: Explore 195 Pages of Insights, 368 Tables, and 24 Figures"

Anti-Mullerian Hormone Test Market Projected to Reach $586.48 million by 2030 - Exclusive Report by 360iResearch

Retrieved on: 
Sabato, Aprile 27, 2024
Use, Polycystic ovary syndrome, Ovarian reserve, PCOS, WHO, Hormone, Danaher Corporation, Primary ovarian insufficiency, Health, World Health Organization, Woman, Infertility, Anti-Müllerian hormone, Health care, AMH, Fertility, Table, Intelligence, IVF, Bio-Rad Laboratories, Privacy, Thermo Fisher Scientific, Diagnosis, POC, Growth, Birth control

Anti-mullerian hormone (AMH) tests are critical in assessing a woman's remaining egg count, potential fertility, and the health of her ovaries.

Key Points: 
  • Anti-mullerian hormone (AMH) tests are critical in assessing a woman's remaining egg count, potential fertility, and the health of her ovaries.
  • A key tool in identifying PCOS is the Anti-Müllerian hormone (AMH) test, which measures the levels of AMH produced by ovarian follicles.
  • We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Anti-Mullerian Hormone Test Market.
  • "Dive into the Anti-Mullerian Hormone Test Market Landscape: Explore 195 Pages of Insights, 368 Tables, and 24 Figures"

3Daughters Named “Startup of the Year” at BioLabs Philadelphia Investor Day 2024

Retrieved on: 
Venerdì, Aprile 19, 2024
Pain, Attention, Hormone, IUD, Safety, Woman, Birth control

MANSFIELD, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- 3Daughters , Inc., a clinical development company fueling evolutionary healthcare for women, was voted the “Startup of Year” by top life science investors and venture capitalists at the 2024 BioLabs Investor Day that took place in Philadelphia on April 16, 2024.

Key Points: 
  • MANSFIELD, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- 3Daughters , Inc., a clinical development company fueling evolutionary healthcare for women, was voted the “Startup of Year” by top life science investors and venture capitalists at the 2024 BioLabs Investor Day that took place in Philadelphia on April 16, 2024.
  • BioLabs Investor Day events are carefully curated, invite-only pitch events where top startups are connected directly with major investors from across the eastern seaboard.
  • Out of 78 applications submitted, 3Daughters was one of 15 companies selected to pitch at the event.
  • Following a competitive pitch process, participating investors anonymously selected 3Daughters as the “Startup of The Year” for 2024.

Beyond IV, the Fourth Generation of the Beyond Burger® and Beyond Beef®, Debuts at Grocery Stores Across the U.S. Including at Walmart and Kroger

Retrieved on: 
Giovedì, Aprile 18, 2024
Sprouts, Beyond Meat, American Heart, Meat, BYND, Walmart, Albertsons, Kroger, Barbecue, Health, Hormone, American Cancer Society, Partnership, Collection, Taste, BBQ, EL, NYT, Gold, Senior, Sodium, Beef, Avocado, Fast food

EL SEGUNDO, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Beyond Meat, Inc. (NASDAQ: BYND), a leader in plant-based meat, today announced the launch of the fourth generation Beyond Burger® and Beyond Beef®, the most significant renovation in the company’s history, at grocery stores nationwide. The new Beyond Burger and Beyond Beef, the company’s tastiest and most nutritious yet, are an excellent source of protein – 21g per serving – and have just 2g of saturated fat derived from avocado oil, with no cholesterol or added antibiotics or hormones. The products’ meatier flavor and taste were preferred over the previous version in consumer testing1, and feedback on the new burger overall has been overwhelmingly positive. Additionally, at a recent conference of registered dietitians, 94% of attendees2 said they enjoyed the taste of the new Beyond Burger, viewed it as healthful, and would recommend it.

Key Points: 
  • The products’ meatier flavor and taste were preferred over the previous version in consumer testing1, and feedback on the new burger overall has been overwhelmingly positive.
  • “I’m so excited about the new Beyond Burger and Beef because not only do they taste incredible, but they’re super nutritious.
  • I feel proud to recommend these products,” said Joy Bauer, renowned registered dietitian, #1 NYT bestselling author and Beyond Meat nutrition advisor.
  • They caramelize and brown beautifully when cooked, and offer the juicy, tender culinary experience of beef.

Ritual Launches the Holy Grail of Fitness: a Tailored, Holistic Approach to Personal Well-Being

Retrieved on: 
Mercoledì, Maggio 1, 2024
Family, Consumer, Health, Fitness & Nutrition, Parenting, Culture, Hormone, Parent, Movement, Life, Athlete, Entertainment

The dynamic program is comprehensive so that it grows with your progress and conforms to your needs and lifestyle.

Key Points: 
  • The dynamic program is comprehensive so that it grows with your progress and conforms to your needs and lifestyle.
  • As integral as the fitness component, Ritual also focuses on monthly lifestyle topics ranging from hormones and gratitude to cold therapy and nutrition.
  • Focused over a longer period of time to build long-standing lifestyle habits, Ritual tackles one lifestyle topic per month.
  • To learn more about becoming a member of Ritual, please visit: www.ritual365.com
    View source version on businesswire.com: https://www.businesswire.com/news/home/20240501737653/en/

Exeltis USA, Inc. Launches Blues Away®, a First-of-its-Kind Postpartum Mood Support Dietary Supplement* for New Mothers Experiencing Postpartum Blues

Retrieved on: 
Venerdì, Aprile 12, 2024
Women, General Health, Health, Mental Health, Family, Baby, Maternity, Vitamins, Supplements, Consumer, Addiction, Brain, Canada Research Chair, Sadness, Woman, Hormone, Business development, Research, CAMH, Mental health, Irritability, Crying, Mother, Multimedia, Sleep deprivation, Progesterone, Anxiety, Birth control

Blues Away® is a single, 3-day shake regimen available without a prescription and will initially be sold on Amazon.

Key Points: 
  • Blues Away® is a single, 3-day shake regimen available without a prescription and will initially be sold on Amazon.
  • “Blues Away® was created with carefully selected and studied ingredients to bolster nutrient levels and support women’s overall mood and emotional well-being during the postpartum phase.
  • Previous research revealed that levels of the hormones estrogen and progesterone plummet abruptly postpartum and can lead to postpartum blues, which Blues Away® may help address.
  • Postpartum blues, also known as “baby blues,” refers to a temporary and common emotional state that many mothers experience within the first few weeks after giving birth.

Evofem Strengthens Phexxi Intellectual Property with New Composition of Matter Patent From USPTO

Retrieved on: 
Giovedì, Aprile 18, 2024
FDA, Patient, Lactic acid, Orange, Pregnancy, Woman, OTCQB, Hormone, Orange Book, Citric acid, Birth, Patent, SAN, Birth control

SAN DIEGO, April 18, 2024 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM) announced today that the United States Patent and Trademark Office (USPTO) issued to the Company a Notice of Allowance for patent application 17/823,020 entitled, "Compositions and Methods for Enhancing the Efficacy of Contraceptive Microbicides." This Notice of Allowance is expected to result in the issuance of a U.S. patent once administrative processes are completed.

Key Points: 
  • This Notice of Allowance is expected to result in the issuance of a U.S. patent once administrative processes are completed.
  • The allowed claims cover methods of contraception with a composition that encompasses Phexxi® (lactic acid, citric acid, and potassium bitartrate) vaginal gel.
  • The patent, when issued, will be Evofem's fifth patent for Phexxi in the United States.
  • "This patent allowance attests to the innovation Phexxi brings to contraception and a woman's ability to protect herself from unintended pregnancy with no hormones."

Natural Cycles Receives HCPCS Level II Code from Centers for Medicare & Medicaid Services (CMS) for its birth control app

Retrieved on: 
Mercoledì, Aprile 17, 2024
FDA, CMS, HCPCS, Pregnancy, Food, De novo, Hormone, Natural Cycles, Insurance, Thermoregulation, Medicare, Temperature, Medical device

NEW YORK, April 17, 2024 /PRNewswire/ -- Natural Cycles, a leading women's digital health company and maker of the world's first birth control app, announced the Centers for Medicare & Medicaid Services ("CMS") established a new HCPCS (Healthcare Common Procedure Coding System) Level II code to identify Natural Cycles. The Natural Cycles code, A9293, became effective on April 1, 2024.

Key Points: 
  • The code will be used to facilitate the processing of health insurance claims by insurers, helping Natural Cycles users get reimbursed for their non-hormonal birth control method
    NEW YORK, April 17, 2024 /PRNewswire/ -- Natural Cycles, a leading women's digital health company and maker of the world's first birth control app, announced the Centers for Medicare & Medicaid Services ("CMS") established a new HCPCS (Healthcare Common Procedure Coding System) Level II code to identify Natural Cycles.
  • The HCPCS level II code makes it easier for insurers to cover a subscription to the Natural Cycles birth control app.
  • The Natural Cycles app, which received the Food and Drug Administration's (FDA's) De Novo clearance in 2018, is used to prevent pregnancy naturally without hormones.
  • The HCPCS level II code will ensure Natural Cycles is described consistently across the healthcare industry, making it easier for insurers to cover a subscription to the FDA Cleared Natural Cycles birth control app.